A consensus prognostic gene expression classifier for ER positive breast cancer
-
* Corresponding authors: Andrew E Teschendorff aet21@cam.ac.uk - Carlos Caldas cc234@cam.ac.uk
- Equal contributors
Genome Biology 2006, 7:R101 doi:10.1186/gb-2006-7-10-r101
Accesses
- Last 30 days: 62 accesses
- Last year: 729 accesses
- All time: 6113 accesses
Cited by
BioMed Central: 19 citations
|
Prognostic gene network modules in breast cancer hold promise Andrew E Teschendorff, Yan Jiao, Carlos Caldas Breast Cancer Research 2010, 12:317 (8 December 2010) |
|
Gad Abraham, Adam Kowalczyk, Sherene Loi, Izhak Haviv, Justin Zobel BMC Bioinformatics 2010, 11:277 (25 May 2010) |
|
Survival prediction from clinico-genomic models - a comparative study Hege M Bøvelstad, Ståle Nygård, Ørnulf Borgan BMC Bioinformatics 2009, 10:413 (13 December 2009) |
|
Intrinsic bias in breast cancer gene expression data sets Jonathan D Mosley, Ruth A Keri BMC Cancer 2009, 9:214 (29 June 2009) |
|
Effects of sample size on robustness and prediction accuracy of a prognostic gene signature Seon-Young Kim BMC Bioinformatics 2009, 10:147 (16 May 2009) |
|
Approaches towards expression profiling the response to treatment Andrew H Sims, John MS Bartlett Breast Cancer Research 2008, 10:115 (8 December 2008) |
|
Fabien Reyal, Martin H van Vliet, Nicola J Armstrong, Hugo M Horlings, Karin E de Visser, Marlen Kok, Andrew E Teschendorff, Stella Mook, Laura van 't Veer, Carlos Caldas, Remy J Salmon, Marc Vijver, Lodewyk FA Wessels Breast Cancer Research 2008, 10:R93 (13 November 2008) |
|
Martin H van Vliet, Fabien Reyal, Hugo M Horlings, Marc J van de Vijver, Marcel JT Reinders, Lodewyk FA Wessels BMC Genomics 2008, 9:375 (6 August 2008) |
|
Pratyaksha Wirapati, Christos Sotiriou, Susanne Kunkel, Pierre Farmer, Sylvain Pradervand, Benjamin Haibe-Kains, Christine Desmedt, Michail Ignatiadis, Thierry Sengstag, Frédéric Schütz, Darlene R Goldstein, Martine Piccart, Mauro Delorenzi Breast Cancer Research 2008, 10:R65 (28 July 2008) |
|
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer Grace M Callagy, Mark J Webber, Paul DP Pharoah, Carlos Caldas BMC Cancer 2008, 8:153 (29 May 2008) |
|
Elizabeth M Azzato, Kristy E Driver, Fabienne Lesueur, Mitul Shah, David Greenberg, Douglas F Easton, Andrew E Teschendorff, Carlos Caldas, Neil E Caporaso, Paul DP Pharoah Breast Cancer Research 2008, 10:R47 (28 May 2008) |
|
Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists Jonathan D Mosley, Ruth A Keri BMC Medical Genomics 2008, 1:11 (25 April 2008) |
|
Emma Niméus-Malmström, Morten Krogh, Per Malmström, Carina Strand, Irma Fredriksson, Per Karlsson, Bo Nordenskjöld, Olle Stål, Görel Östberg, Carsten Peterson, Mårten Fernö Breast Cancer Research 2008, 10:R34 (22 April 2008) |
|
A gene sets approach for identifying prognostic gene signatures for outcome prediction Seon-Young Kim, Yong Sung Kim BMC Genomics 2008, 9:177 (16 April 2008) |
|
Merging microarray data from separate breast cancer studies provides a robust prognostic test Lei Xu, Aik Tan, Raimond L Winslow, Donald Geman BMC Bioinformatics 2008, 9:125 (27 February 2008) |
|
Building pathway clusters from Random Forests classification using class votes Herbert Pang, Hongyu Zhao BMC Bioinformatics 2008, 9:87 (6 February 2008) |
|
Suet F Chin, Andrew E Teschendorff, John C Marioni, Yanzhong Wang, Nuno L Barbosa-Morais, Natalie P Thorne, Jose L Costa, Sarah E Pinder, Mark A van de Wiel, Andrew R Green, Ian O Ellis, Peggy L Porter, Simon Tavaré, James D Brenton, Bauke Ylstra, Carlos Caldas Genome Biology 2007, 8:R215 (7 October 2007) High resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer, and provides a genome-wide list of common copy number alterations associated with aberrant expression and poor prognosis. |
|
Zhe Zhang, Dechang Chen, David A Fenstermacher BMC Genomics 2007, 8:331 (20 September 2007) |
|
Andrew E Teschendorff, Ahmad Miremadi, Sarah E Pinder, Ian O Ellis, Carlos Caldas Genome Biology 2007, 8:R157 (2 August 2007) A feature selection method was used in an analysis of three major microarray expression datasets to identify molecular subclasses and prognostic markers in estrogen receptor-negative breast cancer, showing that it is a heterogeneous disease with at least four main subtypes. |